BR112013020873A2 - endoprótese e método para revestimento de uma endoprótese - Google Patents

endoprótese e método para revestimento de uma endoprótese

Info

Publication number
BR112013020873A2
BR112013020873A2 BR112013020873A BR112013020873A BR112013020873A2 BR 112013020873 A2 BR112013020873 A2 BR 112013020873A2 BR 112013020873 A BR112013020873 A BR 112013020873A BR 112013020873 A BR112013020873 A BR 112013020873A BR 112013020873 A2 BR112013020873 A2 BR 112013020873A2
Authority
BR
Brazil
Prior art keywords
stent graft
coating
graft
general formula
following general
Prior art date
Application number
BR112013020873A
Other languages
English (en)
Inventor
Erika Hoffman
Helmut Horbach
Martin Erdtmann
Michael Hoffmann
Roland Horres
Original Assignee
Hemoteq Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hemoteq Ag filed Critical Hemoteq Ag
Publication of BR112013020873A2 publication Critical patent/BR112013020873A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/02—Processes for applying liquids or other fluent materials performed by spraying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A61L2420/02—Methods for coating medical devices

Abstract

endoprótese e método para revestimento de uma endoprótese. a presente invenção se refere a uma endoprótese com revestimento de droga compreendendo ou consistindo em pelo menos um agente antibiótico e pelo menos uma substância adicional possuindo a seguinte fórmula geral.
BR112013020873A 2011-03-11 2012-02-14 endoprótese e método para revestimento de uma endoprótese BR112013020873A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011014386A DE102011014386A1 (de) 2011-03-11 2011-03-11 Endoprothese mit einer Wirkstoffbeschichtung
PCT/DE2012/100035 WO2012122973A1 (de) 2011-03-11 2012-02-14 Endoprothese mit einer wirkstoffbeschichtung

Publications (1)

Publication Number Publication Date
BR112013020873A2 true BR112013020873A2 (pt) 2016-09-27

Family

ID=46051639

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013020873A BR112013020873A2 (pt) 2011-03-11 2012-02-14 endoprótese e método para revestimento de uma endoprótese

Country Status (15)

Country Link
US (1) US9968573B2 (pt)
EP (1) EP2683421B1 (pt)
JP (1) JP5964867B2 (pt)
KR (1) KR101724083B1 (pt)
CN (1) CN103796690B (pt)
AU (1) AU2012228807B2 (pt)
BR (1) BR112013020873A2 (pt)
CA (1) CA2827546A1 (pt)
DE (2) DE102011014386A1 (pt)
ES (1) ES2643169T3 (pt)
IL (1) IL227793A (pt)
MX (1) MX344324B (pt)
PL (1) PL2683421T3 (pt)
RU (1) RU2592367C2 (pt)
WO (1) WO2012122973A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013213252A1 (de) * 2013-07-05 2015-01-08 Schülke & Mayr GmbH Verwendung eines Isopropanol enthaltenden Mittels zur Bekämpfung von Caliciviridae
CN106267367B (zh) * 2015-06-03 2021-05-14 中国科学院理化技术研究所 一种可用于糖尿病患者的牙种植体的制备方法
CN105566146A (zh) * 2016-03-10 2016-05-11 济宁市化工研究院 D-泛醇三乙酸酯的制备方法
RU2619836C1 (ru) * 2016-07-26 2017-05-18 Акционерное общество "Медсил" Антимикробная композиция на основе силоксанового каучука
RU2630985C1 (ru) * 2016-10-06 2017-09-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский государственный медицинский университет имени академика Е.А. Вагнера" Министерства здравоохранения Российской Федерации Способ интраоперационной профилактики инфекции области хирургического вмешательства при герниопластике сетчатыми имплантами
RU2642303C1 (ru) * 2016-11-29 2018-01-24 Акционерное общество "Федеральный научно-производственный центр "Алтай" Полимерная композиция для нанесения на эндопротезы для реконструктивно-восстановительной хирургии
CN106831470B (zh) * 2016-12-30 2018-11-13 杭州鑫富科技有限公司 D-泛醇三乙酸酯的制备方法
US11666681B2 (en) * 2018-08-13 2023-06-06 Ethicon, Inc. Abradable therapeutic coatings and devices including such coatings
RU2740132C9 (ru) * 2019-04-28 2021-04-01 Евгений Геннадьевич Объедков Способ нанесения коллагеностимулирующего покрытия на эндопротез
RU2756357C1 (ru) * 2021-03-30 2021-09-29 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ покрытия синтетического герниоимплантата для достижения коллагенстимулирующего и противовоспалительного эффекта.

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2891943A (en) * 1954-03-10 1959-06-23 Chemie Grunenthal G M B H Stol Novel antibiotically active products
NL273282A (pt) * 1961-03-30 1900-01-01
US5120738A (en) * 1989-10-06 1992-06-09 Fujirebio Inc. Pantothenic acid derivatives
US5756145A (en) * 1995-11-08 1998-05-26 Baylor College Of Medicine Durable, Resilient and effective antimicrobial coating for medical devices and method of coating therefor
US5912225A (en) * 1997-04-14 1999-06-15 Johns Hopkins Univ. School Of Medicine Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same
US20040062802A1 (en) * 1998-04-02 2004-04-01 Hermelin Victor M. Maximizing effectiveness of substances used to improve health and well being
US6428579B1 (en) * 1998-07-01 2002-08-06 Brown University Research Foundation Implantable prosthetic devices coated with bioactive molecules
EP0998927A1 (en) * 1998-10-30 2000-05-10 Fujirebio Inc. Absorption-enhancing composition for pantothenic acid derivative
JP2002104760A (ja) 2000-09-25 2002-04-10 Hitachi Building Systems Co Ltd 乗客コンベアのリニューアル方法
DE10114247A1 (de) * 2001-03-22 2002-10-10 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Polymer-Kombination
WO2003030956A2 (en) * 2001-10-12 2003-04-17 Osteotech, Inc. Improved bone graft
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
US6982346B2 (en) 2003-07-01 2006-01-03 Isp Investments Inc. Process of making D-panthenyl triacetate
KR20080008364A (ko) * 2005-05-05 2008-01-23 헤모텍 아게 관 스텐트의 전면 코팅
CA2654132A1 (en) 2006-06-02 2007-12-13 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
US8414910B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
WO2008063576A2 (en) * 2006-11-20 2008-05-29 Lutonix, Inc. Drug releasing coatings for medical devices
US8414909B2 (en) * 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
WO2008053051A2 (de) 2006-12-15 2008-05-08 Haering Dietmar Panthenolester ungesättigter carbonsäuren
US20100233288A1 (en) * 2009-03-11 2010-09-16 Teleflex Medical Incorporated Medical devices containing nitroprusside and antimicrobial agents
TWI391605B (zh) * 2009-06-16 2013-04-01 Kwo Ger Metal Technology Inc Force the device
FR2963790B1 (fr) * 2010-08-11 2012-09-28 Pf Medicament Docosahexaeneoate de panthenyle et son utilisation dans le traitement et la prevention des maladies cardiovasculaires

Also Published As

Publication number Publication date
JP5964867B2 (ja) 2016-08-03
CN103796690B (zh) 2016-09-07
US9968573B2 (en) 2018-05-15
DE112012001190A5 (de) 2014-03-27
MX2013010414A (es) 2013-12-02
DE102011014386A1 (de) 2012-09-13
PL2683421T3 (pl) 2018-01-31
CN103796690A (zh) 2014-05-14
KR101724083B1 (ko) 2017-04-06
RU2592367C2 (ru) 2016-07-20
AU2012228807A1 (en) 2013-08-22
ES2643169T3 (es) 2017-11-21
AU2012228807B2 (en) 2015-05-14
EP2683421B1 (de) 2017-07-26
JP2014508013A (ja) 2014-04-03
KR20140007432A (ko) 2014-01-17
US20170014364A1 (en) 2017-01-19
RU2013145502A (ru) 2015-04-20
CA2827546A1 (en) 2012-09-20
IL227793A (en) 2016-08-31
EP2683421A1 (de) 2014-01-15
WO2012122973A1 (de) 2012-09-20
IL227793A0 (en) 2013-09-30
MX344324B (es) 2016-12-13

Similar Documents

Publication Publication Date Title
BR112013020873A2 (pt) endoprótese e método para revestimento de uma endoprótese
BRPI0815649A8 (pt) Revestimento
DOP2014000062A (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
BR112012029517A2 (pt) formulações de fragrância, métodos de fabricação e artigos compreendendo as mesmas.
EA201391626A1 (ru) Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
BR112012027828A2 (pt) composição de matéria, artigo de fabricação e método de redução da viscosidade de uma formulação contendo proteína e de preparação de uma formulação aquosa contendo proteína
GEP201706624B (en) Triazolopyrazine as brd4 inhibitors and usage thereof for cancer treatment
AU2012284088A8 (en) Heterocyclic compounds and uses thereof
BR112013015010A2 (pt) produto, substrato, composição farmacêutica, uso de um produto, e, método para tratar uma infecção microbiana
BR112013002484A2 (pt) composto, composição farmacêutica, métodos para tratar esclerose múltipla e artrite reumatoide, e, uso de um composto.
UY34108A (es) ?proceso para la fabricación de sustratos revestidos?.
EA201170832A1 (ru) Пуриновые соединения
IN2015DN01286A (pt)
BRPI1014962A2 (pt) composição de revestimento, método, e, artigo revestido
MX2016000675A (es) Derivados de amino-metil-biarilo como inhibidores del factor de complemento d y usos de los mismos.
BR112013020532A2 (pt) revestimento em pó
UA111721C2 (uk) Безформальдегідне покриття для панелей, що містить співполімер полікислоти і порошок алюмосилікату кальцію
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
UA107183C2 (uk) Феніламіно-ізонікотинамідні сполуки, їх застосування, фармацевтична композиція, що їх містить, та спосіб лікування гіперпроліферативних захворювань
BR112013024968A2 (pt) composição farmacêutica, e, método de tratamento de uma convulsão
NZ615593A (en) Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
EA201270728A1 (ru) Пуриновые соединения
BR112015011515A2 (pt) Composições farmacêuticas de inibidores de cetp
BR112012019920A2 (pt) derivados de piridazina úteis como agonístas de canabinoide-2.
EA201290954A1 (ru) Композиция для топического применения

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL